InstalabLoading...
InstalabLoading...
Your cells run on a molecule called NAD+ (nicotinamide adenine dinucleotide). It shuttles energy during metabolism, activates enzymes that repair DNA, and regulates the stress-response proteins that help determine how quickly you age. When NAD+ does its job, it picks up electrons and becomes NADH, its "spent" form. The balance between these two forms, the NAD/NADH ratio, is one of the most fundamental indicators of whether your cellular machinery is running smoothly or falling behind.
A higher ratio (more NAD+ relative to NADH) generally signals that your cells are in an active, well-functioning metabolic state. A lower ratio (more NADH accumulating) suggests your cells may be struggling to process fuel efficiently, a pattern linked to metabolic disease, cardiovascular problems, and accelerated aging. This test gives you a direct window into that balance.
NAD+ and NADH are two sides of the same coin. NAD+ is the oxidized, "ready to work" form. NADH is the reduced, "carrying electrons" form. Hundreds of enzymes in your body depend on the cycling between these two states to burn glucose, metabolize fat, and run the energy-producing chain inside your mitochondria (the small power generators inside each cell). The ratio between them reflects your cellular energy balance.
Beyond energy production, NAD+ is consumed outright by three families of enzymes that perform non-energy functions. Sirtuins use NAD+ to regulate gene expression and protect against aging. PARPs use it to repair damaged DNA. And CD38, an immune-signaling enzyme, breaks it down as part of inflammation and immune activation. All three of these compete for the same NAD+ pool, which means your ratio reflects not just energy metabolism but also how much repair work, stress response, and immune activity your body is handling at any given time.
NAD+ levels drop as you get older. Brain imaging studies using magnetic resonance spectroscopy have confirmed age-related reductions in the NAD+/NADH ratio in healthy human brains, with NAD+ falling and NADH rising over time. Plasma studies tell a similar story: an analysis of adults aged 20 to 87 found that both NAD+ and its phosphorylated partner NADP+ declined with age, while their reduced forms (NADH and NADPH) increased, pointing toward a progressive shift in the body's chemical balance.
A study of 1,518 adults in China measured whole-blood NAD levels and found an average of 33.0 ± 5.5 micromoles per liter (a unit measuring very small concentrations in blood). Men had significantly higher levels than women (34.5 vs. 31.3), and the decline with age was most pronounced in men, particularly during middle age. Women showed no significant age-related trend in this study. These sex-based differences add a layer of complexity to interpreting your own results.
A German study of 205 healthy adults aged 18 to 83 found that women had a higher plasma NAD+/NADH ratio than men (median 1.33 versus 1.09). This sex gap narrowed with age, particularly when researchers looked at biological aging markers rather than birth year alone. These findings mean that a "normal" ratio for a 40-year-old woman may look different from a "normal" ratio for a 40-year-old man, and comparing your results to a single universal reference range can be misleading.
A low NAD+/NADH ratio is tied to the cluster of problems that define metabolic syndrome: insulin resistance, obesity, and impaired fat burning. When too much NADH accumulates relative to NAD+, it creates what researchers call "reductive stress," a state where the excess electron load jams up mitochondrial function. This impairs the activity of sirtuin-3, one of the protective enzymes inside mitochondria, and disrupts normal fat processing.
The Jidong Community Study, which measured whole-blood NAD+ (not the ratio specifically) in 1,394 adults, found a striking relationship with metabolic disease. Compared to those in the lowest NAD+ quarter, people in the highest quarter were about 3 times as likely to have metabolic disease (adjusted odds ratio 3.01). Those with 3 to 6 metabolic disease components were over 4 times as likely to be in the highest NAD+ quarter (odds ratio 4.30). This counterintuitive finding, where higher NAD+ was associated with more metabolic disease, may reflect compensatory upregulation: the body producing more NAD+ in response to metabolic stress. It is also a reminder that total NAD+ levels and the NAD+/NADH ratio are related but distinct measurements, and findings from one do not automatically apply to the other.
Abnormal NAD+/NADH ratios are linked to several cardiovascular conditions, including heart failure, high blood pressure, and the damage that occurs when blood flow is temporarily cut off and then restored (called ischemia-reperfusion injury). In diabetic heart disease specifically, a decreased mitochondrial NAD+/NADH ratio impairs the heart's ability to function and promotes oxidative damage.
A study of cardiac patients found that blood NAD+ was significantly lower in people with moderate to severe heart failure (13 micromoles per liter) compared to healthy controls (18 micromoles per liter). While this measured NAD+ levels rather than the ratio directly, it reinforces that NAD+ depletion is a feature of cardiovascular disease that this test can help you track.
NAD+ depletion and altered ratios are implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The mechanisms involve compromised neuronal plasticity (the brain's ability to form new connections), impaired DNA repair, and cellular aging. Brain imaging research has shown that NAD+ levels and the NAD+/NADH ratio decline in healthy human brains with age, suggesting this is a process that begins long before any symptoms appear.
No standardized clinical reference ranges or risk-stratification tiers exist for the NAD/NADH ratio. No major medical guidelines recommend specific cutpoints for clinical decision-making. The values below come from research studies and represent what has been observed in specific populations using specific lab methods. Your own lab may use a different assay with different expected ranges, so these should be treated as orientation points rather than clinical benchmarks.
| Measurement | Reported Value | Population |
|---|---|---|
| Plasma NAD+/NADH ratio (women) | Median 1.33 | 205 healthy German adults, ages 18 to 83 |
| Plasma NAD+/NADH ratio (men) | Median 1.09 | 205 healthy German adults, ages 18 to 83 |
| Whole-blood NAD+ | 33.0 ± 5.5 µmol/L | 1,518 Chinese adults |
Because assay methods, sample handling, and extraction techniques vary significantly between labs, any single number should be compared only to results from the same lab using the same method. Cross-lab comparisons are unreliable with current technology.
A single NAD/NADH ratio reading is a snapshot of a highly dynamic system. NAD+ has a half-life measured in minutes in some tissues, and the ratio fluctuates with your circadian rhythm, recent meals, exercise, and stress levels. One reading cannot distinguish between a true baseline and a transient dip caused by a hard workout the day before or a night of poor sleep.
This is exactly why serial measurement matters more than any single result. Get a baseline reading under standardized conditions (fasted, rested, same time of day). If you are making changes, whether starting a supplement, adjusting your exercise routine, or modifying your diet, retest in 8 to 12 weeks to see whether your ratio is moving in the right direction. Then monitor at least every 6 months. Over time, your personal trend line tells you far more than any comparison to a population average. Because this is a Tier 3 research marker without consensus cutpoints, your own trajectory is the most meaningful reference range you have.
Several common situations can temporarily distort your NAD/NADH ratio and lead you to the wrong conclusion about your metabolic health.
Sample handling is another major source of error. NADH and NADPH can degrade by up to 50% within 24 hours in extracted samples if not properly preserved, and the oxidized and reduced forms can convert into each other during the extraction process. A result that looks abnormal may simply reflect how the sample was processed rather than what is happening inside your cells.
The NAD/NADH ratio sits firmly in the research and exploratory category. No professional medical society recommends it for routine screening, risk stratification, or preventive care. The American Heart Association has acknowledged that altered NAD+/NADH ratios are linked to cardiovascular conditions including hypoxia, ischemia, and atherosclerosis, but also states that accurate assessment of redox status remains technically difficult.
That said, this is a newer measurement catching a wave of scientific interest. Getting a baseline now, understanding your personal trend, and tracking how your ratio responds to the interventions you are already making gives you data that will only become more interpretable as the science matures. You do not need to wait for consensus guidelines to start collecting your own numbers.
Evidence-backed interventions that affect your NAD/NADH Ratio level
NAD/NADH Ratio is best interpreted alongside these tests.